Cent Eur J Public Health 2025, 33(3):170-175 | DOI: 10.21101/cejph.a8739

The importance of screening asymptomatic patients admitted to healthcare facilities during the COVID-19 pandemic

Petr Smejkal1, 2, Filip Hrubý2, Anna Horňáková1
1 Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
2 Institute for Clinical and Experimental Medicine, Prague, Czech Republic

Objectives: Screening of asymptomatic patients upon hospital admission became a key strategy to prevent nosocomial transmission of SARS-CoV-2 during the COVID-19 pandemic, particularly in facilities treating immunocompromised patients. Rapid antigen tests (RATs) were widely used due to their speed, but their reliability in detecting potentially infectious individuals remained debated. In parallel, the role of immunosuppression, especially in solid organ transplant (SOT) recipients, as a risk factor for asymptomatic positivity and prolonged viral shedding raised additional concerns. The aim of the study was to evaluate the diagnostic performance of rapid antigen testing compared to RT-PCR in asymptomatic patients admitted to a high-risk hospital, and the difference in SARS-CoV-2 PCR positivity between asymptomatic patients with and without a history of solid organ transplantation.

Methods: We retrospectively analysed 17,086 paired RAT and RT-PCR tests collected from 11,858 asymptomatic patients admitted to a tertiary care hospital between October 2020 and October 2022. Viral load was assessed via PCR cycle threshold (Ct) values. The sensitivity and specificity of RATs were calculated using PCR as the reference (Ct < 28).

Results: RATs showed a sensitivity of 83.5% and a specificity of 99.3% in detecting patients with high viral loads (Ct < 28). False negatives occurred predominantly in cases with low viral loads (Ct ≥ 28). SARS-CoV-2 PCR positivity was significantly higher in SOT patients (5.4%) than in non-transplant patients (3.2%) (p < 0.001), a difference that was consistent across viral variants.

Conclusions: RATs reliably identified the majority of asymptomatic patients with high viral loads who pose a risk of in-hospital transmission. SOT recipients represent a high-risk subgroup for asymptomatic SARS-CoV-2 carriage, underscoring the importance of rigorous admission screening protocols in specialized healthcare settings.

Klíčová slova: COVID-19, SARS-CoV-2, antigen test, RT-PCR, transplant patients, asymptomatic infection, hospital screening, cycle threshold value

Vloženo: 25. červenec 2025; Revidováno: 27. září 2025; Přijato: 27. září 2025; Zveřejněno: 30. září 2025  Zobrazit citaci

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Smejkal P, Hrubý F, Horňáková A. The importance of screening asymptomatic patients admitted to healthcare facilities during the COVID-19 pandemic. Cent Eur J Public Health. 2025;33(3):170-175. doi: 10.21101/cejph.a8739.
Sdílet...
Stáhnout citaci
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • PDF bude odemčeno 31.3.2026

    Reference

    1. Oran DP, Topol EJ. The proportion of SARS-CoV-2 infections that are asymptomatic: a systematic review. Ann Intern Med. 2021;174(5):655-62. Přejít k původnímu zdroji... Přejít na PubMed...
    2. Pereira MR, Arcasoy S, Farr MA, Mohan S, Emond JC, Tsapepas DS, et al. Outcomes of COVID-19 in solid organ transplant recipients: a matched cohort study. Transpl Infect Dis. 2021;23(4):e13637. doi:10.1111/tid.13637. Přejít k původnímu zdroji... Přejít na PubMed...
    3. Vafea MT, Haidar G. COVID-19 prevention in solid organ transplant recipients: current state of the evidence. Infect Dis Clin North Am. 2023;37(3):459-73. Přejít k původnímu zdroji... Přejít na PubMed...
    4. Tuček M. COVID-19 in the Czech Republic 2020: probable transmission of the coronavirus SARS-CoV-2. Cent Eur J Public Health. 2021;29(2):159-61. Přejít k původnímu zdroji... Přejít na PubMed...
    5. Drain PK. Rapid diagnostic testing for SARS-CoV-2. N Engl J Med. 2022;386(3):264-72. Přejít k původnímu zdroji... Přejít na PubMed...
    6. Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;8(8):CD013705. doi:10.1002/14651858.CD013705. Přejít k původnímu zdroji... Přejít na PubMed...
    7. Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med. 2021;18(8):e1003735. doi: 10.1371/journal.pmed.1003735. Přejít k původnímu zdroji... Přejít na PubMed...
    8. Krüger LJ, Gaeddert M, Köppel L, Brümmer LE, Gottschalk C, Miranda IB, et al. Evaluation of the accuracy, ease of use and limit of detection of novel, rapid, antigen-detecting point-of-care diagnostics for SARS-CoV-2. medRxiv [Preprint]. 2020 Oct 4:2020.10.01.20203836. doi: 10.1101/2020.10.01.20203836. Přejít k původnímu zdroji...
    9. Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 test sensitivity - a strategy for containment. N Engl J Med. 2020;383(22):e120. doi: 10.1056/NEJMp2025631. Přejít k původnímu zdroji... Přejít na PubMed...
    10. Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2021;7(1):eabd5393. doi: 10.1126/sciadv.abd5393. Přejít k původnímu zdroji... Přejít na PubMed...
    11. Gavurová B, Rigelský M. Perception of testing for COVID-19 during the first wave of the pandemic in Slovakia with emphasis on population age groups. Cent Eur J Public Health. 2022;30(2):93-8. Přejít k původnímu zdroji... Přejít na PubMed...
    12. Pavelka M, Van-Zandvoort K, Abbott S, Sherratt K, Majdan M; CMMID COVID-19 working group; et al. The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science. 2021;372(6542):635-41. Přejít k původnímu zdroji... Přejít na PubMed...
    13. van Kampen JJA, van de Vijver DAMC, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12(1):267. doi: 10.1038/s41467-020-20568-4. Přejít k původnímu zdroji... Přejít na PubMed...
    14. Tarhini H, Recoing A, Bridier-Nahmias A, Rahi M, Lambert C, Martres P, et al. Long-term severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection. J Infect Dis. 2021;223(9):1522-7. Přejít k původnímu zdroji... Přejít na PubMed...
    15. Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N Engl J Med. 2020;383(23):2291-3. Přejít k původnímu zdroji... Přejít na PubMed...
    16. Pak TR, Rhee C, Wang R, Klompas M. Discontinuation of universal admission testing for SARS‑CoV‑2 and hospital‑onset COVID‑19 infections in England and Scotland. JAMA Intern Med. 2023;183(6):877-80. Přejít k původnímu zdroji... Přejít na PubMed...

    Zpět na obsah